Vascular viewpoint

Vascular Medicine

Volumn 6, Issue 4, 2001, Pages 269-270

  Anand, Sonia S ^a  

^a HAMILTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN;

BLEEDING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG SAFETY; FEMALE; FOLLOW UP; GASTROCNEMIUS MUSCLE; HUMAN; LONG TERM CARE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NOTE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE; ARTICLE; ORAL DRUG ADMINISTRATION; TIME; TREATMENT OUTCOME; VEIN THROMBOSIS;

ADMINISTRATION, ORAL; ANTICOAGULANTS; HUMANS; PULMONARY EMBOLISM; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 0035726007     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358836X0100600413     Document Type: Note

References (2)

1. Low recurrence rate after deep calf-vein thrombosis with 6 weeks of oral antocoagulation
2. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism